lenvatinib mesylate

Name: Pharmaffiliates
Address: Plot Number 225 ,Industrial Area, Phase II, Panchkula, 134109, IN
Telephone: +91-172-5066494
Price range: $650-$950

Lenvatinib is approved for the treatment of differentiated thyroid cancer that is either locally recurrent or metastatic, progressive, and did not respond to treatment with radioactive iodine. It is an anti-cancer drug. Reference standards of Lenvatinib Mesylate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Lenvatinib Mesylate - API Standards 
    [catalogue_number] => PA 39 03000
    [category_ids] => ,79,80,78,70,82,88,
    [chemical_name] => 
    [weight] => 522.96
    [form] => C22H23ClN4O7S
    [cas] => 857890-39-2
    [pslug] => 857890-39-2-lenvatinib-mesylate-api-pa3903000
    [latest_product] => 0
    [linkproducts] => 1
    [offers_id] => 8
    [offers_name] => Ready Stock
    [offers_status] => 1
    [offers_start_date] => 2024-12-16
    [offers_end_date] => 2024-12-31
    [pageview] => 2
    [offers_slug] => ready-stock
    [offers_product_id] => 48194
    [offers_product_code] => PA 39 03000
    [offers_master_id] => 8
    [offer_percentage] => 20 % OFF
    [offers_product_main_cat] => Pharmaceutical Reference Standards
)